Glucotrack (GCTK) Change in Account Payables (2010 - 2025)
Glucotrack (GCTK) posted Change in Account Payables of -$392000.0 for Q4 2025, up 58.07% on a QoQ basis from -$935000.0 in Q3 2025, and up 54.73% year-over-year from -$253337.3 in Q4 2024.
Glucotrack (GCTK) Change in Account Payables (2010 - 2025) Analysis & Trends
Glucotrack's Change in Account Payables history runs 16 years deep, the most recent figure standing at -$392000.0 for Q4 2025.
- Quarterly Change in Account Payables rose 54.73% year-over-year to -$392000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $325000.0 (up 23.57% YoY) and the FY2025 annual result came in at $325000.0, up 23.57% from the prior year.
- Change in Account Payables was -$392000.0 for Q4 2025 at Glucotrack, up from -$935000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $1.7 million in Q2 2024 and bottomed at -$935000.0 in Q3 2025.
- A 5-year average of $28600.0 and a median of -$23500.0 in 2021 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2021 — Change in Account Payables sank 1633.33% — and 2024, when it jumped 1446.15%.
- Glucotrack's Change in Account Payables stood at -$34000.0 in 2021, then dropped by 26.47% to -$43000.0 in 2022, then plunged by 902.33% to -$431000.0 in 2023, then slumped by 100.93% to -$866000.0 in 2024, then jumped by 54.73% to -$392000.0 in 2025.
- Business Quant data shows GCTK's Change in Account Payables at -$392000.0 in Q4 2025, -$935000.0 in Q3 2025, and $1.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | - |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -52.50 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | - |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 6.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | - |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | - |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | - |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -100.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 4.93 Mn |
| 10 | Glucotrack | 33.48 | -7.38 Mn | - | -392,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -392,000.00 |
| Dec 31, 2025 | -392,000.00 |
| Sep 30, 2025 | -935,000.00 |
| Sep 30, 2025 | -935,000.00 |
| Jun 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.03 Mn |
| Mar 31, 2025 | 620,000.00 |
| Mar 31, 2025 | 620,000.00 |
| Dec 31, 2024 | -866,000.00 |
| Dec 31, 2024 | -866,000.00 |
| Sep 30, 2024 | -768,000.00 |
| Sep 30, 2024 | -768,000.00 |
| Jun 30, 2024 | 1.72 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 175,000.00 |
| Mar 31, 2024 | 175,000.00 |
| Dec 31, 2023 | -431,000.00 |
| Dec 31, 2023 | -431,000.00 |
| Sep 30, 2023 | 425,000.00 |
| Sep 30, 2023 | 425,000.00 |